Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials

por Yood, Robert A, Ottery, Faith D, Irish, William, Wolfson, Marsha
Publicado 2014

Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study

por Omlin, Aurelius, Blum, David, Wierecky, Jan, Haile, Sarah R., Ottery, Faith D., Strasser, Florian
Publicado 2013

Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy

por Baraf, Herbert S. B., Yood, Robert A., Ottery, Faith D., Sundy, John S., Becker, Michael A.
Publicado 2014

Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast can...

por Yao, Hsuan-Ming, Jones, Sarah Ruta, Morales, Serafin, Moosavi, Shahrzad, Zhang, Jeffrey, Freyman, Amy, Ottery, Faith D.
Publicado 2021

Long-term safety of pegloticase in chronic gout refractory to conventional treatment

por Becker, Michael A, Baraf, Herbert S B, Yood, Robert A, Dillon, Aileen, Vázquez-Mellado, Janitzia, Ottery, Faith D, Khanna, Dinesh, Sundy, John S
Publicado 2013

PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen(®)): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety o...

por Yao, Hsuan-Ming, Ottery, Faith D., Borema, Troy, Harris, Stuart, Levy, Jeffrey, May, Tom B., Moosavi, Shahrzad, Zhang, Jeffrey, Summers, Martin
Publicado 2019

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

por Neal-Perry, Genevieve, Cano, Antonio, Lederman, Samuel, Nappi, Rossella E., Santoro, Nanette, Wolfman, Wendy, English, Marci, Franklin, Catherine, Valluri, Udaya, Ottery, Faith D.
Publicado 2023

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

por Baraf, Herbert SB, Becker, Michael A, Gutierrez-Urena, Sergio R, Treadwell, Edward L, Vazquez-Mellado, Janitzia, Rehrig, Claudia D, Ottery, Faith D, Sundy, John S, Yood, Robert A
Publicado 2013

Self‐Completion of the Patient‐Generated Subjective Global Assessment Short Form Is Feasible and Is Associated With Increased Awareness on Malnutrition Risk in Patients With Head a...

por Jager‐Wittenaar, Harriët, de Bats, Hester F., Welink‐Lamberts, Bertine J., Gort‐van Dijk, Dorienke, van der Laan, Bernard F. A. M., Ottery, Faith D., Roodenburg, Jan L. N.
Publicado 2019